OrthoAccel Technologies Committed to Plans for Positioning the United Kingdom as a Key Strategic Market for New Orthodontic Technology

HOUSTON, September 15, 2010 - OrthoAccel Technologies, Inc. (www.acceledent.co.uk/home) has
announced commercial plans for the United Kingdom that entail considerable
business activity and economic impact. Last year, the Company hired a
Director of Sales
(www.acceledent.co.uk/news/Top-performing-Sales-Manager-Joins-OrthoAccel-UK)
based in Wales. Recently, a full-market UK release
(www.acceledent.co.uk/news/OrthoAccel-Technologies-Announces-Full-Market-Release-of-AcceleDent)
of the AcceleDent System was reported. In conjunction with this product
introduction at the British Orthodontic Conference, OrthoAccel has publicized
plans to host a private lecture and reception (www.acceledent.co.uk/news)
to provide scientific data and education to doctors on this new technology
that shortens orthodontic treatment time.

    (Photo: photos.prnewswire.com/prnh/20100915/DA64878)
    (Photo: www.newscom.com/cgi-bin/prnh/20100915/DA64878)

    (Logo: photos.prnewswire.com/prnh/20091029/DA01250LOGO)
    (Logo: www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO)

AcceleDent (www.acceledent.co.uk/how-it-works) is a simple,
removable dental device that patients place in the mouth for twenty minutes
daily. It produces a gentle vibrational force which enhances the pressure
applied by braces. AcceleDent has been clinically proven to safely speed up
orthodontic tooth movement (www.acceledent.co.uk/how-it-works). The
product is hands-free and allows the user flexibility to carry out most
routine tasks during use.

Mike Kaufman, VP of Marketing and Business Development at OrthoAccel
(www.acceledent.co.uk/home) explained, "We really made every effort to
develop an easy-to-use device that would fit into a patient's daily routine
with no trouble or inconvenience."

And patients agree that the Company has accomplished just that.

"I am usually watching television or reading journals whilst using
AcceleDent," reported one adult patient, who is a physician and under the
care of Dr Asif Chatoo, a London-based orthodontic specialist
(www.acceledent.co.uk/home). She continued, "I am extremely pleased
with my orthodontic treatment and feel that AcceleDent has helped me achieve
the cosmetic result I hoped for in a short time period. I absolutely would
recommend it to someone undergoing orthodontic treatment."

So now that AcceleDent, which was made available last year to a select
group of orthodontic specialists (www.acceledent.co.uk/home), will be
available to all orthodontists in the United Kingdom, what comes next?

"We view the UK as a very important strategic market," shared Mike Lowe,
CEO of OrthoAccel. "We anticipate continued investment in a country that we
consider a critical entry point into the EU Region. In addition to our sales
and marketing investment, we are currently conducting analysis as to the most
effective way of establishing a corporate presence and true legal entity in
the UK. Since our founding in 2007, and through our development stage, we
have created a number of jobs here in the states, and the prospect of
crafting economic value in other parts of the world as well is very
exciting."

That value, however, is not limited to commercialization.

"We are also currently in the process of partnering with a renowned
dental hospital to conduct a clinical trial in the UK as early as 2011,"
added Kaufman. "We intend to build the reputation of AcceleDent
(www.acceledent.co.uk/home) and our company OrthoAccel
(www.acceledent.co.uk/home) on clinical outcome studies that add to
the body of evidence based medicine. "

OrthoAccel is anticipating the conclusion of another US clinical trial at
the UT Health Science Center in San Antonio (orthodontics.uthscsa.edu)
with a target completion date later in 2010.

About OrthoAccel Technologies, Inc.

Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately
owned medical device company currently engaged in the development,
manufacturing, and marketing of products to enhance dental care and
orthodontic treatment.

About the AcceleDent System

AcceleDent represents the first clinical approach to safely accelerate
orthodontic tooth movement via modulating biology. The device has been
studied clinically and applies gentle pulsing forces in combination with
standard orthodontics to move teeth faster through accelerated bone
remodeling. Importantly, the device works complementary with all existing
orthodontic technologies. AcceleDent is neither FDA cleared nor FDA approved;
it is currently investigational only in the United States. More information
can be found at www.acceledent.com or requested via
info@orthoaccel.com

Michael K. Lowe, CEO of OrthoAccel Technologies, Inc., +1-832-631-1659